| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 66 | 2025 | 1036 | 5.430 |
Why?
|
| CpG Islands | 37 | 2025 | 333 | 3.110 |
Why?
|
| Epigenesis, Genetic | 22 | 2025 | 712 | 2.950 |
Why?
|
| Colorectal Neoplasms | 17 | 2025 | 621 | 2.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2024 | 110 | 1.760 |
Why?
|
| Carcinogenesis | 4 | 2024 | 342 | 1.560 |
Why?
|
| Colonic Neoplasms | 9 | 2023 | 249 | 1.270 |
Why?
|
| Promoter Regions, Genetic | 17 | 2015 | 1211 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2025 | 1942 | 0.880 |
Why?
|
| Gene Silencing | 13 | 2012 | 224 | 0.880 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 37 | 0.830 |
Why?
|
| DNA | 5 | 2021 | 1430 | 0.710 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 162 | 0.580 |
Why?
|
| Microbiota | 2 | 2021 | 429 | 0.560 |
Why?
|
| Polymerase Chain Reaction | 10 | 2009 | 1490 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 607 | 0.510 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 1901 | 0.490 |
Why?
|
| Cell Differentiation | 6 | 2015 | 1852 | 0.470 |
Why?
|
| Mutation | 11 | 2017 | 5933 | 0.450 |
Why?
|
| Microsatellite Repeats | 6 | 2011 | 230 | 0.420 |
Why?
|
| Mice | 18 | 2024 | 17619 | 0.410 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 416 | 0.410 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2009 | 124 | 0.410 |
Why?
|
| Nuclear Proteins | 9 | 2012 | 1220 | 0.410 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 794 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 1011 | 0.400 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2009 | 481 | 0.390 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1574 | 0.370 |
Why?
|
| Intestinal Mucosa | 6 | 2015 | 755 | 0.370 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 974 | 0.360 |
Why?
|
| Intestines | 1 | 2015 | 580 | 0.350 |
Why?
|
| Cell Line, Tumor | 21 | 2014 | 3474 | 0.350 |
Why?
|
| Stem Cells | 1 | 2015 | 678 | 0.340 |
Why?
|
| Neoplasm Proteins | 6 | 2009 | 666 | 0.320 |
Why?
|
| Gene Expression Profiling | 8 | 2010 | 1783 | 0.310 |
Why?
|
| Humans | 70 | 2025 | 126134 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 1381 | 0.300 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 4 | 2015 | 148 | 0.290 |
Why?
|
| DNA, Neoplasm | 8 | 2009 | 287 | 0.290 |
Why?
|
| Animals | 19 | 2024 | 33230 | 0.280 |
Why?
|
| DNA Modification Methylases | 4 | 2021 | 48 | 0.280 |
Why?
|
| Azacitidine | 6 | 2009 | 51 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2021 | 588 | 0.270 |
Why?
|
| Folic Acid | 3 | 2024 | 277 | 0.270 |
Why?
|
| Fluorouracil | 1 | 2007 | 135 | 0.260 |
Why?
|
| Neoplasms | 9 | 2021 | 2841 | 0.260 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 1498 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2009 | 722 | 0.260 |
Why?
|
| Histones | 7 | 2021 | 507 | 0.250 |
Why?
|
| Colon | 5 | 2010 | 354 | 0.250 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2005 | 19 | 0.250 |
Why?
|
| Aged | 22 | 2025 | 20078 | 0.250 |
Why?
|
| Temperature | 1 | 2007 | 285 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1218 | 0.240 |
Why?
|
| Long Interspersed Nucleotide Elements | 4 | 2010 | 36 | 0.240 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2332 | 0.230 |
Why?
|
| Middle Aged | 27 | 2025 | 27402 | 0.230 |
Why?
|
| Adenoma | 4 | 2010 | 139 | 0.230 |
Why?
|
| Male | 37 | 2025 | 62225 | 0.230 |
Why?
|
| Genomic Structural Variation | 1 | 2025 | 92 | 0.210 |
Why?
|
| Melanoma | 2 | 2009 | 927 | 0.210 |
Why?
|
| Genome, Human | 4 | 2011 | 1284 | 0.210 |
Why?
|
| Female | 35 | 2025 | 68037 | 0.210 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 786 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 7 | 2014 | 1739 | 0.210 |
Why?
|
| Sulfites | 4 | 2014 | 27 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 439 | 0.200 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 12 | 0.200 |
Why?
|
| Age of Onset | 1 | 2025 | 609 | 0.200 |
Why?
|
| Lysine | 4 | 2008 | 173 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 770 | 0.200 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 32 | 0.200 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 78 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2010 | 1754 | 0.190 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2002 | 62 | 0.190 |
Why?
|
| Cyclins | 1 | 2002 | 94 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 125 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2025 | 4894 | 0.180 |
Why?
|
| Epigenomics | 2 | 2021 | 175 | 0.180 |
Why?
|
| Liver | 1 | 2009 | 1761 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2009 | 966 | 0.180 |
Why?
|
| Adult | 18 | 2025 | 30314 | 0.180 |
Why?
|
| Diet | 2 | 2024 | 1099 | 0.180 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2007 | 170 | 0.170 |
Why?
|
| Aging | 3 | 2017 | 1195 | 0.170 |
Why?
|
| Genome | 2 | 2021 | 490 | 0.170 |
Why?
|
| Cell Cycle | 1 | 2003 | 584 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2012 | 7 | 0.160 |
Why?
|
| Dysbiosis | 1 | 2021 | 137 | 0.160 |
Why?
|
| Environmental Exposure | 1 | 2002 | 211 | 0.160 |
Why?
|
| Infant Nutrition Disorders | 1 | 2019 | 14 | 0.150 |
Why?
|
| Duodenum | 1 | 2019 | 110 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 626 | 0.150 |
Why?
|
| Cell Line | 5 | 2013 | 2570 | 0.140 |
Why?
|
| Celiac Disease | 1 | 2019 | 73 | 0.140 |
Why?
|
| Base Sequence | 8 | 2011 | 2773 | 0.140 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2015 | 24 | 0.140 |
Why?
|
| Aged, 80 and over | 10 | 2012 | 6582 | 0.140 |
Why?
|
| Malnutrition | 1 | 2019 | 148 | 0.130 |
Why?
|
| Machine Learning | 1 | 2020 | 313 | 0.130 |
Why?
|
| Hedgehog Proteins | 2 | 2015 | 197 | 0.130 |
Why?
|
| Adenocarcinoma | 3 | 2009 | 975 | 0.130 |
Why?
|
| Phenotype | 8 | 2010 | 4313 | 0.120 |
Why?
|
| Animals, Suckling | 1 | 2015 | 51 | 0.120 |
Why?
|
| Aurora Kinase C | 1 | 2015 | 2 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2010 | 509 | 0.110 |
Why?
|
| Liver Neoplasms | 3 | 2011 | 1351 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1236 | 0.110 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 84 | 0.110 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 32 | 0.110 |
Why?
|
| Methylation | 2 | 2013 | 198 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2007 | 200 | 0.110 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 37 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2010 | 555 | 0.100 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2013 | 39 | 0.100 |
Why?
|
| Rectum | 2 | 2010 | 99 | 0.100 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 18 | 0.100 |
Why?
|
| Genes, Neoplasm | 3 | 2008 | 83 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 406 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2010 | 994 | 0.100 |
Why?
|
| Chromatin | 3 | 2021 | 488 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 588 | 0.090 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 1070 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2013 | 194 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2391 | 0.090 |
Why?
|
| Algorithms | 2 | 2020 | 1639 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2010 | 396 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2552 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 354 | 0.090 |
Why?
|
| DNA Repair Enzymes | 2 | 2008 | 39 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2752 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 209 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2013 | 765 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 80 | 0.080 |
Why?
|
| Retinoblastoma Protein | 2 | 2008 | 78 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 3604 | 0.080 |
Why?
|
| Apoptosis | 2 | 2007 | 1803 | 0.080 |
Why?
|
| Retroelements | 1 | 2010 | 41 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2007 | 64 | 0.080 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 192 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1434 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2009 | 902 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 42 | 0.080 |
Why?
|
| DNA Primers | 5 | 2010 | 603 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3149 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 117 | 0.080 |
Why?
|
| Hydroxamic Acids | 2 | 2007 | 58 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2009 | 73 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 31 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 4517 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 132 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 180 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2010 | 344 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 280 | 0.070 |
Why?
|
| Butyrates | 1 | 2009 | 41 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 1293 | 0.070 |
Why?
|
| Sp3 Transcription Factor | 1 | 2008 | 7 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 72 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 36 | 0.070 |
Why?
|
| ras Proteins | 2 | 2008 | 140 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 276 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2017 | 4472 | 0.070 |
Why?
|
| Genes, APC | 1 | 2008 | 13 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2012 | 2357 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 911 | 0.070 |
Why?
|
| Centrosome | 1 | 2008 | 24 | 0.070 |
Why?
|
| Prostate | 2 | 2008 | 407 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2008 | 169 | 0.070 |
Why?
|
| Colitis | 1 | 2010 | 156 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 788 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2009 | 90 | 0.070 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 2588 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 58 | 0.070 |
Why?
|
| Tumor Protein p73 | 1 | 2007 | 27 | 0.070 |
Why?
|
| Drug Tolerance | 1 | 2007 | 38 | 0.070 |
Why?
|
| Leucovorin | 1 | 2007 | 52 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 105 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 2038 | 0.070 |
Why?
|
| Survival Rate | 2 | 2009 | 2055 | 0.070 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 714 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 156 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 566 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2006 | 11 | 0.070 |
Why?
|
| Sulfates | 1 | 2007 | 33 | 0.060 |
Why?
|
| Multigene Family | 1 | 2007 | 296 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 179 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 235 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 127 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3260 | 0.060 |
Why?
|
| Cisplatin | 1 | 2007 | 270 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 4 | 2008 | 52 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 277 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 651 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2007 | 355 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2006 | 39 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2008 | 1396 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 101 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2007 | 1019 | 0.060 |
Why?
|
| Adolescent | 6 | 2025 | 19986 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 39 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2006 | 286 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1179 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 1739 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2010 | 224 | 0.060 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 15 | 0.060 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2024 | 56 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 284 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 214 | 0.050 |
Why?
|
| Germ Cells | 1 | 2025 | 196 | 0.050 |
Why?
|
| Child | 5 | 2025 | 25112 | 0.050 |
Why?
|
| Telomerase | 1 | 2024 | 153 | 0.050 |
Why?
|
| Genes, ras | 2 | 2017 | 100 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2010 | 872 | 0.050 |
Why?
|
| Disease Progression | 4 | 2014 | 2110 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 13 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 664 | 0.050 |
Why?
|
| Genes, p53 | 3 | 2009 | 213 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2009 | 12393 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 191 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 85 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 565 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2025 | 352 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 82 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 207 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 83 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 523 | 0.050 |
Why?
|
| Aflatoxins | 1 | 2002 | 3 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 134 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 132 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2008 | 579 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2006 | 681 | 0.050 |
Why?
|
| Risk Factors | 3 | 2009 | 10374 | 0.050 |
Why?
|
| Hepatitis | 1 | 2002 | 55 | 0.050 |
Why?
|
| Carcinogens | 1 | 2002 | 127 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 881 | 0.050 |
Why?
|
| Prognosis | 3 | 2010 | 4697 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 54 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 34 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2021 | 209 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 153 | 0.040 |
Why?
|
| Fibrosis | 1 | 2002 | 394 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 709 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 2 | 2010 | 71 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 780 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1475 | 0.040 |
Why?
|
| Pakistan | 1 | 2019 | 91 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2025 | 14375 | 0.040 |
Why?
|
| Growth | 1 | 2019 | 92 | 0.040 |
Why?
|
| Young Adult | 2 | 2010 | 9635 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 698 | 0.040 |
Why?
|
| Colonic Polyps | 2 | 2010 | 81 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 230 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 469 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 3422 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2019 | 185 | 0.030 |
Why?
|
| LIM Domain Proteins | 2 | 2008 | 65 | 0.030 |
Why?
|
| Karyotyping | 2 | 2008 | 313 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2019 | 298 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2008 | 200 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2009 | 3307 | 0.030 |
Why?
|
| RNA, Untranslated | 2 | 2009 | 109 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2009 | 203 | 0.030 |
Why?
|
| Infant | 3 | 2019 | 12803 | 0.030 |
Why?
|
| HCT116 Cells | 2 | 2007 | 59 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1596 | 0.030 |
Why?
|
| Acetylation | 2 | 2008 | 182 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1221 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2007 | 1013 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 419 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 5107 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 28 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 687 | 0.030 |
Why?
|
| RNA, Long Noncoding | 2 | 2009 | 228 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 96 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 540 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 76 | 0.030 |
Why?
|
| Texas | 1 | 2002 | 3536 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 2766 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 136 | 0.030 |
Why?
|
| Genomics | 2 | 2014 | 1577 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 205 | 0.020 |
Why?
|
| Time Factors | 1 | 2003 | 6030 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 2877 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1706 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 829 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 2604 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 30 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2012 | 54 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2012 | 66 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2010 | 1571 | 0.020 |
Why?
|
| Gambia | 1 | 2010 | 26 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 331 | 0.020 |
Why?
|
| Fertilization | 1 | 2010 | 43 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 81 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 224 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 125 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 49 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2010 | 56 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 94 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 101 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 32 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 53 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 112 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 269 | 0.020 |
Why?
|
| Seasons | 1 | 2010 | 309 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 31 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 301 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 93 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 157 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 113 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 60 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 244 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2008 | 47 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 92 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2008 | 65 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 348 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 164 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2009 | 181 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 561 | 0.020 |
Why?
|
| Urothelium | 1 | 2008 | 60 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 201 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 135 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2008 | 78 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 450 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 739 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 566 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 29 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 122 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 950 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4433 | 0.020 |
Why?
|
| Remission Induction | 1 | 2007 | 298 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 95 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2007 | 25 | 0.020 |
Why?
|
| Friedreich Ataxia | 1 | 2007 | 48 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 175 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 243 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 248 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 211 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 337 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 133 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2006 | 42 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 729 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2007 | 109 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 329 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 264 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 86 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8381 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2006 | 7 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 432 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 363 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 79 | 0.020 |
Why?
|
| Cadherins | 1 | 2007 | 174 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 1193 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 726 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 762 | 0.010 |
Why?
|
| Quinazolines | 1 | 2006 | 179 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 425 | 0.010 |
Why?
|
| Mesoderm | 1 | 2006 | 104 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 656 | 0.010 |
Why?
|
| Leukemia | 1 | 2008 | 354 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2009 | 437 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 399 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 840 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 537 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1408 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1823 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 527 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1067 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 898 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 1922 | 0.010 |
Why?
|
| DNA Repair | 1 | 2007 | 552 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 599 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 426 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 1039 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1598 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2906 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1298 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 3394 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1604 | 0.010 |
Why?
|
| Palliative Care | 1 | 2006 | 437 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 871 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1097 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6178 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 2014 | 0.010 |
Why?
|